BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 16478170)

  • 1. Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA.
    Puerta DT; Botta M; Jocher CJ; Werner EJ; Avedano S; Raymond KN; Cohen SM
    J Am Chem Soc; 2006 Feb; 128(7):2222-3. PubMed ID: 16478170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
    Laus S; Ruloff R; Tóth E; Merbach AE
    Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging.
    Silvério S; Torres S; Martins AF; Martins JA; André JP; Helm L; Prata MI; Santos AC; Geraldes CF
    Dalton Trans; 2009 Jun; (24):4656-70. PubMed ID: 19513474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity.
    Xu J; Churchill DG; Botta M; Raymond KN
    Inorg Chem; 2004 Sep; 43(18):5492-4. PubMed ID: 15332797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field.
    Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E
    Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxometric evaluation of novel manganese(II) complexes for application as contrast agents in magnetic resonance imaging.
    Aime S; Anelli L; Botta M; Brocchetta M; Canton S; Fedeli F; Gianolio E; Terreno E
    J Biol Inorg Chem; 2002 Jan; 7(1-2):58-67. PubMed ID: 11862541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast and easy access to efficient bifunctional chelators for MRI applications.
    Gugliotta G; Botta M; Giovenzana GB; Tei L
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3442-4. PubMed ID: 19477128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics.
    Burai L; Tóth E; Sour A; Merbach AE
    Inorg Chem; 2005 May; 44(10):3561-8. PubMed ID: 15877439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
    Werner EJ; Datta A; Jocher CJ; Raymond KN
    Angew Chem Int Ed Engl; 2008; 47(45):8568-80. PubMed ID: 18825758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward optimized high-relaxivity MRI agents: the effect of ligand basicity on the thermodynamic stability of hexadentate hydroxypyridonate/catecholate gadolinium(III) complexes.
    Doble DM; Melchior M; O'Sullivan B; Siering C; Xu J; Pierre VC; Raymond KN
    Inorg Chem; 2003 Aug; 42(16):4930-7. PubMed ID: 12895117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrocyclic Gd3+ chelates attached to a silsesquioxane core as potential magnetic resonance imaging contrast agents: synthesis, physicochemical characterization, and stability studies.
    Henig J; Tóth E; Engelmann J; Gottschalk S; Mayer HA
    Inorg Chem; 2010 Jul; 49(13):6124-38. PubMed ID: 20527901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
    Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
    Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpected aggregation of neutral, xylene-cored dinuclear GdIII chelates in aqueous solution.
    Costa J; Balogh E; Turcry V; Tripier R; Le Baccon M; Chuburu F; Handel H; Helm L; Tóth E; Merbach AE
    Chemistry; 2006 Sep; 12(26):6841-51. PubMed ID: 16770815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AAZTA-based bifunctional chelating agents for the synthesis of multimeric/dendrimeric MRI contrast agents.
    Gugliotta G; Botta M; Tei L
    Org Biomol Chem; 2010 Oct; 8(20):4569-74. PubMed ID: 20740241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel cholic acid-based contrast enhancement agent for targeted MRI.
    Chong HS; Song HA; Lim S; Macrenaris K; Ma X; Lee H; Bui P; Meade T
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2505-8. PubMed ID: 18337094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A starburst-shaped heterometallic compound incorporating six densely packed gd(3+) ions.
    Livramento JB; Sour A; Borel A; Merbach AE; Tóth E
    Chemistry; 2006 Jan; 12(4):989-1003. PubMed ID: 16311990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.
    Ladd DL; Hollister R; Peng X; Wei D; Wu G; Delecki D; Snow RA; Toner JL; Kellar K; Eck J; Desai VC; Raymond G; Kinter LB; Desser TS; Rubin DL
    Bioconjug Chem; 1999; 10(3):361-70. PubMed ID: 10346865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and complexation properties of DTPA-N,N''-bis[bis(n-butyl)]-N'-methyl-tris(amide). Kinetic stability and water exchange of its Gd3+ complex.
    Jaszberényi Z; Tóth E; Kálai T; Király R; Burai L; Brücher E; Merbach AE; Hideg K
    Dalton Trans; 2005 Feb; (4):694-701. PubMed ID: 15702179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dual lanthanide probe suitable for optical (Tb3+ luminescence) and magnetic resonance imaging (Gd3+ relaxometry).
    Picard C; Geum N; Nasso I; Mestre B; Tisnès P; Laurent S; Muller RN; Elst LV
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5309-12. PubMed ID: 16919942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.